
In 1665, Robert Hooke peered through a microscope — a relatively novel tool for biologists — and discovered the cell, changing our fundamental understanding of life. Today, microscopy is revealing how immune cells kill tumor cells and how cancer evades our normal defenses. Unraveling these complex relationships has revolutionized cancer care through the development of treatments like immunotherapies, which boost the immune system’s ability to fight cancer. But immunotherapies currently only work for a fraction of people with cancer, and researchers are investigating how to widen the circle of people who can benefit.
Take a journey with us and see what our researchers see through sophisticated microscopes as they carefully observe cellular activity and reveal how the immune system interacts with cancer.
An Immune Cell Engages Its Target
An Immune Cell Eliminates Its Target
A Multi-Cell Attack
Using advanced microscopy techniques, researchers at Genentech discovered that cancer cells can repair their membranes after T cells poke holes in them, which prevents a lethal dose of toxin from entering and killing the cancer cells. Inhibiting this repair mechanism made T cells more effective at killing cancer cells in the lab, suggesting potential avenues for developing new immunotherapies. The study was led by Alex Ritter, PhD, a former Genentech postdoctoral researcher, and Ira Mellman, PhD, Vice President of Cancer Immunology at Genentech.
Visual observation has been the foundation of discovery — from evolution, to astronomy, to virology — since the beginning of scientific inquiry. Cancer biology is no exception, and for those studying the interactions between immune and tumor cells, the microscope remains a powerful tool. As microscopy technologies and techniques continue to evolve, so will our understanding of life, disease, and new ways to restore health.
To learn more about Genentech’s groundbreaking research, visit https://www.gene.com/topics/behind-the-science